Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Considering competing risks . . . Not all black and white.

Cauley JA, Ensrud KE.

Arch Intern Med. 2008 Apr 28;168(8):793-5. doi: 10.1001/archinte.168.8.793. No abstract available.

PMID:
18443252
[PubMed - indexed for MEDLINE]
2.

Alendronate and atrial fibrillation.

Cummings SR, Schwartz AV, Black DM.

N Engl J Med. 2007 May 3;356(18):1895-6. No abstract available.

PMID:
17476024
[PubMed - indexed for MEDLINE]
Free Article
3.

Yearly zoledronic acid in postmenopausal osteoporosis.

Karam R, Camm J, McClung M.

N Engl J Med. 2007 Aug 16;357(7):712-3; author reply 714-5. No abstract available.

PMID:
17703529
[PubMed - indexed for MEDLINE]
4.

[Osteoporosis and bisphosphonates].

Zuber MA.

Z Rheumatol. 2007 Dec;66(8):713-5. German. No abstract available.

PMID:
17955251
[PubMed - indexed for MEDLINE]
5.

[Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].

Ringe JD.

MMW Fortschr Med. 2009 Mar 5;151(10):7. German. No abstract available.

PMID:
19472655
[PubMed - indexed for MEDLINE]
6.

[Thiazolidinediones and skeletal health].

Meier C, Bodmer M, Meier CR, Kraenzlin ME.

Rev Med Suisse. 2009 Jun 10;5(207):1309-10, 1312-3. Review. French.

PMID:
19626930
[PubMed - indexed for MEDLINE]
7.

Alendronate, osteoporosis, and atherosclerosis.

Strandberg TE.

Arch Intern Med. 2008 Nov 24;168(21):2386-7; author reply 2387. doi: 10.1001/archinte.168.21.2386-c. No abstract available.

PMID:
19029508
[PubMed - indexed for MEDLINE]
8.

Yearly zoledronic acid in postmenopausal osteoporosis.

Poole KE, Kaptoge S, Reeve J.

N Engl J Med. 2007 Aug 16;357(7):711-2; author reply 714-5. No abstract available.

PMID:
17703530
[PubMed - indexed for MEDLINE]
9.

Use of alendronate and risk of incident atrial fibrillation in women.

Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM.

Arch Intern Med. 2008 Apr 28;168(8):826-31. doi: 10.1001/archinte.168.8.826.

PMID:
18443257
[PubMed - indexed for MEDLINE]
10.

Thiazolidinedione use and the risk of fractures.

Reblin T.

CMAJ. 2009 Apr 14;180(8):841. doi: 10.1503/cmaj.1090005. No abstract available.

PMID:
19364797
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Thiazolidinedione use and the risk of fractures.

Toulis KA, Goulis DG, Anastasilakis AD.

CMAJ. 2009 Apr 14;180(8):841-2; author reply 842-3. doi: 10.1503/cmaj.1090003. No abstract available.

PMID:
19364796
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Bisphosphonates and the risk of atrial fibrillation.

Sewerynek E, Stuss M.

Endokrynol Pol. 2011 Jan-Feb;62(1):93-6. Review.

PMID:
21365587
[PubMed - indexed for MEDLINE]
Free Article
13.

Rosiglitazone and pioglitazone. Beware fractures.

Dixit A, Pandey P.

BMJ. 2009 Sep 29;339:b3957. doi: 10.1136/bmj.b3957. No abstract available.

PMID:
19808816
[PubMed - indexed for MEDLINE]
14.

What's the story with Fosamax? Recent reports have women wondering if they should stop taking this widely prescribed osteoporosis drug.

[No authors listed]

Harv Womens Health Watch. 2008 Nov;16(3):1-2. No abstract available.

PMID:
19043857
[PubMed - indexed for MEDLINE]
15.

[Osteoporotic fracture in menopausal women: alendronate reduces the risk].

Bize R, Lamy O, Peytremann-Bridevaux I.

Rev Med Suisse. 2008 Dec 10;4(183):2703. French. No abstract available.

PMID:
19157286
[PubMed - indexed for MEDLINE]
16.

Diabetes drug pioglitazone (Actos): risk of fracture.

Meymeh RH, Wooltorton E.

CMAJ. 2007 Sep 25;177(7):723-4. Epub 2007 Sep 6. No abstract available.

PMID:
17823139
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Study confirms link between certain diabetes drugs and fractures.

[No authors listed]

Harv Womens Health Watch. 2010 May;17(9):6. No abstract available.

PMID:
20593558
[PubMed - indexed for MEDLINE]
18.

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.

Loke YK, Singh S, Furberg CD.

CMAJ. 2009 Jan 6;180(1):32-9. doi: 10.1503/cmaj.080486. Epub 2008 Dec 10.

PMID:
19073651
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Fracture risk is a class effect of glitazones.

Short R.

BMJ. 2007 Mar 17;334(7593):551. No abstract available.

PMID:
17363794
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk